Share
Journal Information
Issue
Vol. 27. Issue S1.Special issue on hepatocellular carcinoma (HCC) and hepatitis B and C as its main causes worldwide
(January 2022)
Hepatitis B and C viruses and hepatocellular carcinoma
Giovanni Raimondo, Joao R. Rebello-Pinho, Arturo Panduro
Ann Hepatol. 2022;27 Supl 1:100650
Open access
Influence of genetic and environmental risk factors in the development of hepatocellular carcinoma in Mexico
Luis E. Gomez-Quiroz, Sonia Roman
Ann Hepatol. 2022;27 Supl 1:100649
Open access
The ITA.LI.CA Consortium: How multicentre collaboration helped shape the management of patients with hepatocellular carcinoma on the basis of real-world evidence
Franco Trevisani, Edoardo G. Giannini
Ann Hepatol. 2022;27 Supl 1:100564
Open access
Prevalence of hepatitis B and C viral infections in hospitalized patients with increased liver enzyme levels and with no known history of hepatic disease
Irene Cacciola, Concetta Pitrone, Maria Stella Franzè, Carmelo Mazzeo, Marco Muscianisi, Serena Porcari, Giusy Pintabona, Carmela Morace, ... Giovanni Raimondo
Ann Hepatol. 2022;27 Supl 1:100578
Open access
A hospital-based study of the prevalence of HBV, HCV, HIV, and liver disease among a low-income population in West Mexico
Saul Laguna-Meraz, Sonia Roman, Alexis Jose-Abrego, Ramon Sigala-Arellano, Arturo Panduro
Ann Hepatol. 2022;27 Supl 1:100579
Open access
Hepatitis B infection in Mexican adults: Results of a nationally representative survey
Martha Carnalla, Dèsirée Vidaña-Pérez, Celia Alpuche-Aranda, Norberto C. Chávez-Tapia, Martín Romero-Martínez, Teresa Shamah-Levy, Tonatiuh Barrientos-Gutiérrez
Ann Hepatol. 2022;27 Supl 1:100583
Open access
Prevalence and risk factors of hepatitis C virus infection in the rural northeastern United States
Kelley Chan, Neeraj Mangla
Ann Hepatol. 2022;27 Supl 1:100576
Open access
Twenty-year follow-up of an outbreak of hepatitis C in a small rural town of Argentina: The O'Brien Project
Federico Guillermo Villamil, Nancy Elena Massenzio, Patricia Cristina Baré, Paula Andrea Cocco, Fernando Mario Cairo, Gastón Rafael Picchio
Ann Hepatol. 2022;27 Supl 1:100577
Open access
Hepatitis B virus genotypes and subgenotypes and the natural history and epidemiology of hepatitis B
Tania Queiroz Reuter, Michele Gomes-Gouvea, Samira Chuffi, Ulisses Horst Duque, José Americo Carvalho, Waltesia Perini, Marcello Moro Queiroz, Ingrid Marques Segal, ... João Renato Rebello Pinho
Ann Hepatol. 2022;27 Supl 1:100574
Open access
Analysis of the complete genome of HBV genotypes F and H found in Brazil and Mexico using the next generation sequencing method
Patrícia Oliveira Gionda, Michele Gomes-Gouvea, Fernanda de Mello Malta, Pedro Sebe, Ana Paula Moreira Salles, Rodrigo dos Santos Francisco, Alexis José-Abrego, Sonia Roman, ... João Renato Rebello Pinho
Ann Hepatol. 2022;27 Supl 1:100569
Open access
Prognostic factors in hepatocellular carcinoma patients with Child-Pugh A liver function after hepatectomy: Not related to the surgical approach
Sheng Wei, Minghao Yang, Xiaoping Geng, Qiru Xiong, Hui Hou, Dachen Zhou, Xiao Cui
Ann Hepatol. 2022;27 Supl 1:100580
Open access
Direct-acting antiviral agents and risk of Hepatocellular carcinoma: Critical appraisal of the evidence
Ciro Celsa, Caterina Stornello, Paolo Giuffrida, Carmelo Marco Giacchetto, Mauro Grova, Gabriele Rancatore, Concetta Pitrone, Vito Di Marco, ... Giuseppe Cabibbo
Ann Hepatol. 2022;27 Supl 1:100568
Open access
MiR-3682 promotes the progression of hepatocellular carcinoma (HCC) via inactivating AMPK signaling by targeting ADRA1A
Wenyue Zhao, Xueping Liu
Ann Hepatol. 2022;27 Supl 1:100570
Open access
miR-221-3p regulates hepatocellular carcinoma cell proliferation, migration and invasion via targeting LIFR
Wei Tan, Zhuokai Li, Weifen Xia, Jinde Zhu, Rengen Fan
Ann Hepatol. 2022;27 Supl 1:100567
Open access
Knockdown of long non-coding RNA LINC01006 represses the development of hepatocellular carcinoma by modulating the miR-194-5p/CADM1 axis
Zhaoxia Sun, Li Zhao, Shuang Wang, Honggang Wang
Ann Hepatol. 2022;27 Supl 1:100571
Open access
Publish in
Annals of Hepatology
Special content about COVID-19
- Outcomes and factors associated with relapse of vaccine-induced liver injury after SARS CoV-2 immunization: A nationwide study
- Matrix metalloproteinase-2 inducing COL1A1 synthesis via integrin alpha Ⅴ promotes invasion and metastasis of cholangiocarcinoma cells
- P-2 NASH IS IMPROVED THROUGH MODIFICATIONS IN H3K9 METHYLATION BY PIRFENIDONE ACTING AS JMJD2B DEMETHYLASE ANTAGONIST.
- O-2 EVALUATION OF RISK FACTORS AND PROGNOSIS OF HEPATOCELLULAR CARCINOMA RECURRENCE AFTER LIVER TRANSPLANTATION
Affiliated societies
